this quarter saw higher scrap costs and weaker SMRT cell yields. Operating expenses were down 22% as the company has continued to reduce headcount and cut spending where possible. PacBio ended the ...
Throughput—With a high-density, 25 million ZMW SMRT Cell, up to 4 SMRT Cells in parallel, and 24-hour run times, the Revio system delivers 360 Gb of HiFi reads per day, equivalent to 1,300 human whole ...
Zacks Investment Research on MSN4d
Here's Why You Should Retain PacBio Stock in Your Portfolio NowPacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback